Troubleshooting Emerging Technology Companies

One of the problems of being asked for advice is that the recipients don’t always like what they are told. This was memorably illustrated by one of the first ever reality TV shows, Troubleshooter, featuring former ICI chairman Sir John Harvey Jones. Never afraid to give blunt advice, Harvey-Jones’ solutions to struggling businesses ranged from developing  turn around plans to …

Advertisements

The Market for Nanotechnology in Drug Delivery in 2021 – Nanocarriers vs Drug Nanocrystals

There are two different approaches to Nanotechnology in Drug Delivery,  making drug crystals smaller to increase solubility and bioavailability, or using some form of carrier to deliver them in a more effective manner. If we look at the total market size in 2021, it is a 60/40 split in favour of drug nano crystals although we feel that developing new delivery mechanisms …

The Market for Nanotechnology in Drug Delivery in 2010. And The Winners Are…

Cientifica Ltd published Nanotechnology in Drug Delivery 2011  on 2 November 2011. Here’s a few of the key findings.   MARKET ANALYSIS BY KEY TECHNOLOGY   Of All Key Technologies Studied… An analysis of the Total Addressable Market (TAM) in 2010, for nanotechnology in drug delivery (NDD), all key technologies studied shows the following values in 2010 (by descending order): Drug Nanocrystals (596 …

What Use Is Nanotechnology?

Technology Review, besides being a great magazine edited by Jason Pontin, who I have known since the heyday of Red Herring, also puts on some great conferences. So I was excited and honoured to be invited to EmTech Spain, a two day conference in Malaga focussing on emerging technologies. Along with my World Economic Forum colleague Javier García Martínez of …

Innovation Starvation or Risk Avoidance?

While working on our report on Using Emerging Technologies to Address Global Risks, one of my favourite SciFi authors, Neal Stephenson, popped up with an essay on Innovation Starvation. It echoes Tyler Cowen‘s arguments that all the easy big stuff has been done,  and that all we have left to look forward to are incremental improvements rather than world changing …

Nanotechnology, Scaffolds, Tissue Engineering and Organ Transplantation

On July 7, 2011, University College London made an announcement of an breakthrough which is an historic landmark in the field of nanotechnology in tissue engineering: surgeons in Sweden have successfully implanted, for the first time ever, a totally synthetic, tissue-engineered organ (a trachea) into a patient suffering from a terminal-stage tracheal cancer. A team leaded by Professor Alexander Seifalian (UCL …

Nanotechnology in Drug Delivery, by Remote Control

Professor Paras N. Prasad, Ph.D. (executive director of University of Buffalo‘s Institute for Lasers, Photonics and Biophotonics and SUNY Distinguished Professor in the Department of Chemistry in the UB College of Arts and Sciences) was a co-author with colleagues from the University of Buffalo‘s Photodynamic Therapy Center at Roswell Park Cancer Institute on a paper published in Molecular Pharmaceutics on April 19, 2006: …

Resuscitating Dead Cells and Tissues: Progress in The Adoption of Nanotechnology in Regenerative Medicine and Tissue Engineering

Each time an individual suffers a heart attack and survives, unfortunately something happens to the heart permanently: some of the cells that constitute this organ die. Those cells can be: Cardiomyocytes (striated muscle cells found in the heart, derived from cardiac myoblasts); Neurons (in the wall of the heart). These dead tissues give to the heart muscles weakening. Consequently, the …

IBM and Nanotechnology in Drug Delivery

The researchers Fredrik Nederberg, Kazuki Fukushima and James L. Hedrick from IBM Research at IBM Almaden Research Center, San Jose, CA, USA and the researchers Ying Zhang, Jeremy P. K. Tan, Chuan Yang, Shujun Gao and Yi-Yan Yang from the Institute of Bioengineering and Nanotechnology, in Singapore made an important discovery in nanomedicine. Their discovery, published online in Nature on 3 …

Why the Adoption of Nanotechnology in Medicine and Biomedicine isn’t as Fast as it Could Be? – Part 4: Delayed Nanoregulation

Most sciences and technologies develop faster than regulators can regulate. This is no secret. Altough this is “normal”, the special case of nanotechnology and its adoption in several fields (including medicine and biomedicine) may be critical. While nanotechnology shows a huge potential for tremendous benefits, this emerging and fast developing field of science and technology also s has the potential to …